Literature DB >> 11423842

Anxiolysis with oral midazolam in pediatric patients undergoing dermatologic surgical procedures.

C C Otley1, T H Nguyen, P K Phillips.   

Abstract

BACKGROUND: Pediatric patients undergoing dermatologic surgical procedures often experience high levels of anxiety. Oral midazolam is a short-acting benzodiazepine that can ameliorate procedure-related anxiety.
OBJECTIVE: Our purpose was to determine the safety and efficacy of oral midazolam as an adjuvant anxiolytic agent for pediatric patients undergoing dermatologic surgical procedures.
METHODS: A prospective series of pediatric patients undergoing dermatologic surgical procedures who received oral midazolam were monitored, and efficacy and complications were recorded.
RESULTS: Oral midazolam provided good to excellent anxiolytic effects in most pediatric patients undergoing painful dermatologic surgical procedures. Because midazolam does not provide analgesic effects, local anesthesia is necessary. Complications were uncommon and minor.
CONCLUSION: Oral midazolam is an effective anxiolytic agent in pediatric patients undergoing dermatologic surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423842     DOI: 10.1067/mjd.2001.114591

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

Review 1.  [Special aspects of dermatologic surgery in children].

Authors:  C Löser; M Möhrle
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

2.  Achieving hemostasis in dermatology - Part 1: Preoperative, intraoperative, and postoperative management.

Authors:  Ravneet Ruby Kaur; Jaimie B Glick; Daniel Siegel
Journal:  Indian Dermatol Online J       Date:  2013-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.